UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy
Cystic fibrosis has become the poster child for precision medicine – most new therapies are carefully tailored to a CF patient’s genetic makeup. University of North Carolina spinout Spyryx Biosciences is proposing a one-size-fits-all approach to the disease: It’s developing a peptide-based therapy that, in theory, could be effective among all CF patients. This startup’s still pre-IND […]